The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
The macrolide antibiotic renaissance
Open accessAbstract
Macrolides represent a large family of protein synthesis inhibitors of great clinical interest due to their applicability to human medicine. Macrolides are composed of a macrocyclic lactone of different ring sizes, to which one or more deoxy‐sugar or amino sugar residues are attached. Macrolides act as antibiotics by binding to bacterial 50S ribosomal subunit and interfering with protein synthesis. The high affinity of macrolides for bacterial ribosomes, together with the highly conserved structure of ribosomes across virtually all of the bacterial species, is consistent with their broad‐spectrum activity. Since the discovery of the progenitor macrolide, erythromycin, in 1950, many derivatives have been synthesised, leading to compounds with better bioavailability and acid stability and improved pharmacokinetics. These efforts led to the second generation of macrolides, including well‐known members such as azithromycin and clarithromycin. Subsequently, in order to address increasing antibiotic resistance, a third generation of macrolides displaying improved activity against many macrolide resistant strains was developed. However, these improvements were accompanied with serious side effects, leading to disappointment and causing many researchers to stop working on macrolide derivatives, assuming that this procedure had reached the end. In contrast, a recent published breakthrough introduced a new chemical platform for synthesis and discovery of a wide range of diverse macrolide antibiotics. This chemical synthesis revolution, in combination with reduction in the side effects, namely, ‘Ketek effects’, has led to a macrolide renaissance, increasing the hope for novel and safe therapeutic agents to combat serious human infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrolides, such as erythromycin, azithromycin, and clarithromycin, inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit and preventing peptide elongation [260,261].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [260]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The carbohydrate-active enzymes database (CAZy) in 2013
Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M., & Henrissat, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1178 · Cited by 6,333
Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Structures of the Bacterial Ribosome at 3.5 Å Resolution
Schuwirth, B. S., Borovinskaya, M. A., Hau, C. W., Zhang, W., Vila-Sanjurjo, A., Holton, J. M., & Cate, J. H. D. (2005) · Science · doi:10.1126/science.1117230 · Cited by 1,418
An Evolving Hierarchical Family Classification for Glycosyltransferases
Coutinho, P. M., Deleury, E., Davies, G. J., & Henrissat, B. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00307-3 · Cited by 1,211
Schlünzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A., & Franceschi, F. (2001) · Nature · doi:10.1038/35101544 · Cited by 1,059
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Southan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Modular Organization of Genes Required for Complex Polyketide Biosynthesis
Donadio, S., Staver, M. J., McAlpine, J. B., Swanson, S. J., & Katz, L. (1991) · Science · doi:10.1126/science.2024119 · Cited by 898
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
The Behavior and Significance of Slow‐Binding Enzyme Inhibitors
Morrison, J. F., & Walsh, C. T. (1988) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123072.ch5 · Cited by 840
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
The anti-Shine–Dalgarno sequence drives translational pausing and codon choice in bacteria
Li, G.-W., Oh, E., & Weissman, J. S. (2012) · Nature · doi:10.1038/nature10965 · Cited by 637
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13354 · Cited by 604
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Ins and Outs of Major Facilitator Superfamily Antiporters
Law, C. J., Maloney, P. C., & Wang, D.-N. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093329 · Cited by 498
Macrolide antibiotics. Chemistry, biology, and practice
Nagel, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740930 · Cited by 475
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464
Tenson, T., Lovmar, M., & Ehrenberg, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00662-4 · Cited by 461
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
Dunkle, J. A., Xiong, L., Mankin, A. S., & Cate, J. H. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007988107 · Cited by 413
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S., & Wootton, J. C. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00696.x · Cited by 358
A platform for the discovery of new macrolide antibiotics
Seiple, I. B., Zhang, Z., Jakubec, P., Langlois-Mercier, A., Wright, P. M., Hog, D. T., Yabu, K., Allu, S. R., Fukuzaki, T., Carlsen, P. N., et al. (2016) · Nature · doi:10.1038/nature17967 · Cited by 351
Kim, S. H., Song, J.-H., Chung, D. R., Thamlikitkul, V., Yang, Y., Wang, H., Lu, M., So, T. M.-K., Hsueh, P.-R., Yasin, R. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05658-11 · Cited by 341
MCGUIRE, J. M., BUNCH, R. L., ANDERSON, R. C., Boaz, H. E., Flynn, E. H., POWELL, H. M., & SMITH, J. W. (1952) · PubMed · Cited by 326
Girard, A. E., Girard, D., English, A. R., Gootz, T. D., Cimochowski, C. R., Faiella, J. A., Haskell, S. L., & Retsema, J. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1948 · Cited by 321
Revisiting the structures of several antibiotics bound to the bacterial ribosome
Bulkley, D., Innis, C. A., Blaha, G., & Steitz, T. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008685107 · Cited by 308
ABC-F Proteins Mediate Antibiotic Resistance through Ribosomal Protection
Sharkey, L. K. R., Edwards, T. A., & O’Neill, A. J. (2016) · mBio · doi:10.1128/mbio.01975-15 · Cited by 284
Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Insights into erythromycin action from studies of its activity as inducer of resistance
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.797 · Cited by 267
Horinouchi, S., & Weisblum, B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7079 · Cited by 262
Molecular Mechanism of Drug-Dependent Ribosome Stalling
Vazquez-Laslop, N., Thum, C., & Mankin, A. S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.026 · Cited by 260
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Resistance to Macrolide Antibiotics in Public Health Pathogens
Fyfe, C., Grossman, T. H., Kerstein, K., & Sutcliffe, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025395 · Cited by 246
BRIGHT, G. M., NAGEL, A. A., BORDNER, J., DESAI, K. A., DIBRINO, J. N., NOWAKOWSKA, J., VINCENT, L., WATROUS, R. M., SCIAVOLINO, F. C., ENGLISH, A. R., et al. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.1029 · Cited by 237
MORIMOTO, S., TAKAHASHI, Y., WATANABE, Y., & OMURA, S. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.187 · Cited by 233
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
Schlünzen, F., Harms, J. M., Franceschi, F., Hansen, H. A. S., Bartels, H., Zarivach, R., & Yonath, A. (2003) · Structure · doi:10.1016/s0969-2126(03)00022-4 · Cited by 231
Macrolide Resistance Genes in Enterococcus spp
Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martinez, J. L., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.967-971.2000 · Cited by 227
Canu, A., Malbruny, B., Coquemont, M., Davies, T. A., Appelbaum, P. C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.125-131.2002 · Cited by 218
Clinical Pharmacokinetics of Clarithromycin
Rodvold, K. A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937050-00003 · Cited by 214
Hepatic safety of antibiotics used in primary care
Andrade, R. J., & Tulkens, P. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr159 · Cited by 213
CURRENT PROGRESS IN STRUCTURE-BASED RATIONAL DRUG DESIGN MARKS A NEW MINDSET IN DRUG DISCOVERY
Lounnas, V., Ritschel, T., Kelder, J., McGuire, R., Bywater, R. P., & Foloppe, N. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201302011 · Cited by 213
Macrolide antibiotics : chemistry, biology, and practice
大村, 智. (2002) · Academic Press eBooks · Cited by 207
Cao, B., Zhao, C., Yin, Y., Zhao, F., Song, S., Bai, L., Zhang, J., Liu, Y., Zhang, Y., Wang, H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/653535 · Cited by 206
Asymmetric total synthesis of erythromycin. 3. Total synthesis of erythromycin
Woodward, R. B., Logusch, E., Nambiar, K. P., Sakan, K., Ward, D. E., Au-Yeung, B. W., Balaram, P., Browne, L. J., Card, P. J., & Chen, C. H. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a051 · Cited by 205
Production and glycosylation of plant‐made pharmaceuticals: the antibodies as a challenge
Gomord, V., Sourrouille, C., Fitchette, A., Bardor, M., Pagny, S., Lerouge, P., & Faye, L. (2004) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2004.00062.x · Cited by 203
Gryczan, T. J., Grandi, G., Hahn, J., Grandi, R., & Dubnau, D. (1980) · Nucleic Acids Research · doi:10.1093/nar/8.24.6081 · Cited by 200
Denis, A., Agouridas, C., Auger, J.-M., Benedetti, Y., Bonnefoy, A., Bretin, F., Chantot, J.-F., Dussarat, A., Fromentin, C., Gouin D'Ambrières, S., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00534-x · Cited by 196
Quirós, L. M., Aguirrezabalaga, I., Olano, C., Méndez, C., & Salas, J. A. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00880.x · Cited by 179
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
The general mode of translation inhibition by macrolide antibiotics
Kannan, K., Kanabar, P., Schryer, D., Florin, T., Oh, E., Bahroos, N., Tenson, T., Weissman, J. S., & Mankin, A. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417334111 · Cited by 175
Morozumi, M., Iwata, S., Hasegawa, K., Chiba, N., Takayanagi, R., Matsubara, K., Nakayama, E., Sunakawa, K., & Ubukata, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00779-07 · Cited by 171
Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel
Kannan, K., Vázquez‐Laslop, N., & Mankin, A. S. (2012) · Cell · doi:10.1016/j.cell.2012.09.018 · Cited by 165
Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants
Berisio, R., Harms, J., Schluenzen, F., Zarivach, R., Hansen, H. A. S., Fucini, P., & Yonath, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.14.4276-4279.2003 · Cited by 165
Programmed drug‐dependent ribosome stalling
Ramu, H., Mankin, A., & Vazquez‐Laslop, N. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06576.x · Cited by 164
Translation regulation via nascent polypeptide-mediated ribosome stalling
Wilson, D. N., Arenz, S., & Beckmann, R. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.01.008 · Cited by 158
Menninger, J. R., & Otto, D. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.5.811 · Cited by 157
Structural basis for selectivity and toxicity of ribosomal antibiotics
Böttger, E. C., Springer, B., Prammananan, T., Kidan, Y. G., & Sander, P. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve062 · Cited by 150
Vázquez‐Laslop, N., Ramu, H., Klepacki, D., Kannan, K., & Mankin, A. S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.180 · Cited by 150
Arenz, S., Ramu, H., Gupta, P., Berninghausen, O., Beckmann, R., Vázquez‐Laslop, N., Mankin, A. S., & Wilson, D. N. (2014) · Nature Communications · doi:10.1038/ncomms4501 · Cited by 148
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides
Wondrack, L. M., Massa, M. A., Yang, B. V., & Sutcliffe, J. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.992 · Cited by 142
Perić, M., Bozdoğan, B., Jacobs, M. R., & Appelbaum, P. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1017-1022.2003 · Cited by 138
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · ChemInform · doi:10.1002/chin.200524271 · Cited by 138
Ramu, H., Vázquez‐Laslop, N., Klepacki, D., Dai, Q., Piccirilli, J. A., Micura, R., & Mankin, A. S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.031 · Cited by 137
Garza‐Ramos, G., Xiong, L., Zhong, P., & Mankin, A. S. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6898-6907.2001 · Cited by 136
The Concise Guide to PHARMACOLOGY 2015/16: Ligand‐gated ion channels
Alexander, S. P. H., Peters, J. A., Kelly, E., Marrion, N. V., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13350 · Cited by 136
Arthur, M., Brisson-Noël, A., & Courvalin, P. M. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.6.783 · Cited by 135
Mechanism and Diversity of the Erythromycin Esterase Family of Enzymes
Morar, M., Pengelly, K., Koteva, K. K., & Wright, G. D. (2012) · Biochemistry · doi:10.1021/bi201790u · Cited by 129
Mechanism of Tet(O)‐mediated tetracycline resistance
Connell, S. R., Trieber, C. A., Dinos, G. P., Einfeldt, E., Taylor, D. E., & Nierhaus, K. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg093 · Cited by 127
Self-citationKetolides—telithromycin, an example of a new class of antibacterial agents
Bryskier, A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00185.x · Cited by 127
Sequence selectivity of macrolide-induced translational attenuation
Davis, A. R., Gohara, D. W., & Yap, M.-N. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410356111 · Cited by 123
Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent
Burdett, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3246-3251.1996 · Cited by 121
Macrolide antibiotics allosterically predispose the ribosome for translation arrest
Sothiselvam, S., Liu, B., Han, W., Ramu, H., Klepacki, D., Atkinson, G. C., Brauer, A., Remm, M., Tenson, T., Schulten, K. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403586111 · Cited by 117
Drug Sensing by the Ribosome Induces Translational Arrest via Active Site Perturbation
Arenz, S., Meydan, S., Starosta, A. L., Berninghausen, O., Beckmann, R., Vázquez‐Laslop, N., & Wilson, D. N. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.014 · Cited by 116
Macrolide antibiotics in the ribosome exit tunnel: species‐specific binding and action
Kannan, K., & Mankin, A. S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06315.x · Cited by 116
O'Hara, K., Kanda, T., Ohmiya, K., Ebisu, T., & Kono, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1354 · Cited by 114
Ma, Z., Clark, R. F., Brazzale, A., Wang, S., Rupp, M., Li, L., Griesgraber, G. W., Zhang, S., Yong, H., Phan, L., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102349 · Cited by 112
Barry, A. L., Jones, R. N., & Thornsberry, C. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.752 · Cited by 111
Felmingham, D., Cantón, R., & Jenkins, S. G. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.006 · Cited by 111
Genetic Approaches to Polyketide Antibiotics. 1
McDaniel, R. N., Welch, M., & Hutchinson, C. R. (2005) · Chemical Reviews · doi:10.1021/cr0301189 · Cited by 111
Generation of polyketide libraries via combinatorial biosynthesis
Khosla, C., & Zawada, R. J. X. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)10046-9 · Cited by 111
NAKAGAWA, Y., Itai, S., YOSHIDA, T., & Nagai, T. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.725 · Cited by 108
The solithromycin journey—It is all in the chemistry
FERNANDES, P. B., Martens, E., Bertrand, D., & Pereira, D. W. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.035 · Cited by 107
Boeckman, R. K., & Pruitt, J. R. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00203a044 · Cited by 105
Or, Y. S., Clark, R. F., Wang, S., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990618n · Cited by 104
Activity of the Ketolide Telithromycin Is Refractory to Erm Monomethylation of Bacterial rRNA
Liu, M., & Douthwaite, S. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1629-1633.2002 · Cited by 104
Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.
BARTHÉLÉMY, P., AUTISSIER, D., Gerbaud, G., & Courvalin, P. M. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1692 · Cited by 103
Farrell, D. J., Douthwaite, S. R., Morrissey, I., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1777-1783.2003 · Cited by 101
Mutations in a 23S rRNA Gene of Chlamydia trachomatis Associated with Resistance to Macrolides
Misyurina, O. Y., Chipitsyna, Е. V., Finashutina, Y. P., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1347-1349.2004 · Cited by 98
Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli
Ounissi, H., & Courvalin, P. M. (1985) · Gene · doi:10.1016/0378-1119(85)90005-8 · Cited by 96
Antibiotic preparations contain DNA: a source of drug resistance genes?
Webb, V., & DAVIES, J. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2379 · Cited by 91
Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells
Chittum, H. S., & Champney, W. S. (1995) · Current Microbiology · doi:10.1007/bf00295501 · Cited by 88
Analysis of the nucleotide sequence of theereBgene encoding the erythromydn esterase type II
Arthur, M., AUTISSIER, D., & Courvalin, P. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.12.4987 · Cited by 85
Species-specific antibiotic-ribosome interactions: implications for drug development
Wilson, D. N., Harms, J., Nierhaus, K. H., Schlünzen, F., & Fucini, P. (2005) · Biological Chemistry · doi:10.1515/bc.2005.141 · Cited by 85
Siibak, T., Peil, L., Xiong, L., Mankin, A. S., Rèmme, J., & Tenson, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-08 · Cited by 85
Mankin, A. S. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.08.003 · Cited by 85
Pfister, P., Corti, N., Hobbie, S. N., Bruell, C. M., Zarivach, R., Yonath, A., & Böttger, E. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501598102 · Cited by 81
Farrell, D. J., Morrissey, I., Bakker, S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3169-3171.2004 · Cited by 80
Ross, J. I., Eady, E. A., Cove, J. H., & Baumberg, S. (1995) · Gene · doi:10.1016/0378-1119(94)00833-e · Cited by 79
McGuire, J. M., BUNCH, R. L., ANDERSON, R. C., Boaz, H. E., Flynn, E. H., POWELL, H. M., & SMITH, J. W. (1952) · PubMed · Cited by 79
Shortridge, V. D., Zhong, P., Cao, Z., Beyer, J. M., Almer, L. S., Ramer, N. C., Doktor, S. Z., & Flamm, R. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.783-786.2002 · Cited by 78
Brockmann, H., & Henkel, W. (1951) · Chemische Berichte · doi:10.1002/cber.19510840306 · Cited by 77
Matsuoka, M., Inoue, M., Endo, Y., et al. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00134-4 · Cited by 77
Macrolide Resistance from the Ribosome Perspective
Franceschi, F. J., Kanyo, Z. F., Sherer, E. C., et al. (2004) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005043340740 · Cited by 76
Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects
Park, S. R., Han, A. R., Ban, Y. H., Yoo, Y. J., Kim, E. J., & Yoon, Y. J. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2326-8 · Cited by 74
Regulation of Gene Expression by Macrolide-Induced Ribosomal Frameshifting
Gupta, P., Kannan, K., Mankin, A. S., & Vázquez‐Laslop, N. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.013 · Cited by 71
Ojo, K. K., Ulep, C. C., van Kirk, N., Luís, H., Bernardo, M. F., Leitão, J. H., & Roberts, M. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3451-3456.2004 · Cited by 67
Kim, Y., Cha, C., & Cerniglia, C. E. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(02)00611-0 · Cited by 65
The ABC of Ribosome-Related Antibiotic Resistance
Wilson, D. N. (2016) · mBio · doi:10.1128/mbio.00598-16 · Cited by 65
Kwak, J., Choi, E. C., & Weisblum, B. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.15.4725-4735.1991 · Cited by 64
Recent Developments on Ketolides and Macrolides
Wu, Y.-J., & Su, W.-G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371671 · Cited by 61
Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard, J., & Douthwaite, S. R. (2003) · PubMed · Cited by 59
Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
Giambattista, M. D., Engelborghs, Y., Nyssen, E., et al. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47454-6 · Cited by 58
Macrolide Resistance–associated 23S rRNA Mutation inMycoplasma genitalium, Japan
Shimada, Y., Deguchi, T., Nakane, K., et al. (2011) · Emerging infectious diseases · doi:10.3201/eid1706.101055 · Cited by 58
Mordi, M. N., Pelta, M. D., Boote, V., Morris, G. A., & Barber, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904811 · Cited by 54
Ojo, K. K., Striplin, M. J., Ulep, C. C., Close, N. S., Zittle, J., Luís, H., Bernardo, M. F., Leitão, J. H., & Roberts, M. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1089-1091.2006 · Cited by 54
Structure and Function of the Macrolide Biosensor Protein, MphR(A), with and without Erythromycin
Zheng, J., Sagar, V., Smolinsky, A., Bourke, C. H., LaRonde-LeBlanc, N. A., & Cropp, T. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.058 · Cited by 53
Release of (oligo) peptidyl-tRNA from ribosomes by erythromycin A.
Otaka, T., & Kaji, A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.7.2649 · Cited by 53
Sothiselvam, S., Neuner, S., Rigger, L., Klepacki, D., Micura, R., Vázquez‐Laslop, N., & Mankin, A. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.018 · Cited by 53
COUNTER, F. T., Ensminger, P. W., Preston, D. A., Wu, C., Greene, J. M., Felty-Duckworth, A. M., Paschal, J. W., & Kirst, H. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1116 · Cited by 50
Mono- and dimethylating activities and kinetic studies of the ermC 23 S rRNA methyltransferase
Denoya, C. D., & Dubnau, D. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81658-7 · Cited by 49
Núñez-Samudio, V., & Chesneau, O. (2012) · Research in Microbiology · doi:10.1016/j.resmic.2012.12.003 · Cited by 48
Mechanisms of resistance to macrolides, lincosamides, and ketolides
Sutcliffe, J. A., & Leclercq, R. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8105-0_17 · Cited by 46
Kono, M., Ohara, K., & Ebisu, T. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90369-y · Cited by 46
Chancey, S. T., Bai, X., Kumar, N., Drábek, E. F., Daugherty, S. C., Colon, T., Ott, S. H., Sengamalay, N. A., Sadzewicz, L., Tallon, L. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116254 · Cited by 43
Hammerschlag, M. R., Roblin, P. M., & Bébéar, C. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_2.25 · Cited by 43
Putnam, S. D., Sader, H. S., Farrell, D. J., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.021 · Cited by 41
Nucleotide Selectivity of Antibiotic Kinases
Shakya, T., & Wright, G. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01570-09 · Cited by 40
Milton, I. D. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90377-z · Cited by 39
Magnamycin. A New Antibiotic1,2
Wagner, R., Hochstein, F. A., Murai, K., et al. (1953) · Journal of the American Chemical Society · doi:10.1021/ja01115a019 · Cited by 39
Liang, C., Yao, S., Chiu, Y.-H., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.027 · Cited by 38
Champney, W. S., & Miller, M. (2002) · Current Microbiology · doi:10.1007/s00284-001-0016-6 · Cited by 37
Structural Basis for Kinase-Mediated Macrolide Antibiotic Resistance
Fong, D. H., Burk, D. L., Blanchet, J., Yan, A. Y., & Berghuis, A. M. (2017) · Structure · doi:10.1016/j.str.2017.03.007 · Cited by 37
Matsuoka, M., Jánosi, L., Endou, K., & Nakajima, Y. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08830.x · Cited by 36
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis
Doucet‐Populaire, F. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.2.179 · Cited by 34
Results from the Solithromycin International Surveillance Program (2014)
Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-16 · Cited by 34
Almutairi, M. M., Park, S. R., Rose, S., Hansen, D. A., Vázquez‐Laslop, N., Douthwaite, S. R., Sherman, D. H., & Mankin, A. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512090112 · Cited by 33
Bommakanti, A. S., Lindahl, L., & Zengel, J. M. (2008) · RNA · doi:10.1261/rna.786408 · Cited by 32
23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22
Berisio, R., Corti, N., Pfister, P., Yonath, A., & Böttger, E. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00767-06 · Cited by 31
Resistance to telithromycin is conferred by msr(A), msrC and msr(D) in Staphylococcus aureus
Reynolds, E., & Cove, J. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki378 · Cited by 30
Macrolide and Ketolide Resistance with Streptococcus pneumoniae
Doern, G. V. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.010 · Cited by 27
Katz, L., Brown, D. P., Boris‐Lawrie, K., & Tuan, J. S. (1987) · Gene · doi:10.1016/0378-1119(87)90291-5 · Cited by 27
Dinos, G. P., Connell, S. R., Nierhaus, K. H., & Kalpaxis, D. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.617 · Cited by 27
Self-citationThe wobbly status of ketolides: where do we stand?
Georgopapadakou, N. H. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954036 · Cited by 26
Prunier, A.-L., Trong, H. N., Tande, D., Segond, C., & Leclercq, R. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.18 · Cited by 26
Telithromycin activity is reduced by efflux in Streptococcus pyogenes
Cantón, R., Mazzariol, A., Morosini, M.-I., Baquero, F., & Cornaglia, G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki033 · Cited by 25
At the Intersection of Chemistry, Biology, and Medicine
Walsh, C. T. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-110716-121241 · Cited by 25
ermK leader peptide: Amino acid sequence critical for induction by erythromycin
Kwon, A., Min, Y.-H., Yoon, E.-J., Kim, J.-A., Shim, M.-J., & Choi, E. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02969307 · Cited by 24
Krokidis, M. G., Marquez, V., Wilson, D. N., Kalpaxis, D. L., & Dinos, G. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01994-13 · Cited by 21
Self-citationChampney, W. S., & Pelt, J. L. (2002) · Current Microbiology · doi:10.1007/s00284-001-0110-9 · Cited by 20
Karahalios, P., Kalpaxis, D. L., Fu, H., Katz, L., Wilson, D. N., & Dinos, G. P. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026567 · Cited by 18
Self-citationKouvela, E. C., Kalpaxis, D. L., Wilson, D. N., & Dinos, G. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01425-08 · Cited by 15
Self-citationAccidental release of antibiotic-resistance genes
Webb, V., & DAVIES, J. E. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90108-2 · Cited by 14
Akshay, S., Bertea, M., Hobbie, S. N., Oettinghaus, B., Shcherbakov, D., Böttger, E. C., & Akbergenov, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01398-10 · Cited by 14
Toward the rational design of macrolide antibiotics to combat resistance
Pavlova, À., Parks, J. M., Oyelere, A. K., & Gumbart, J. C. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13004 · Cited by 12
Synthesis and in vitro antibiotic activity of 16-membered 9-O-arylalkyloxime macrolides
Fu, H., Marquez, S., Gu, X., Katz, L., & Myles, D. C. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.061 · Cited by 11
3D-QSAR and molecular docking for the discovery of ketolide derivatives
Ruan, Z., Huangfu, D., Xu, X., Sun, P., & Chen, W.-M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.774369 · Cited by 9
Vimberg, V., Lenart, J., Janata, J., & Novotna, G. B. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04367-14 · Cited by 8
Krokidis, M. G., Bougas, A., Stavropoulou, M., Kalpaxis, D. L., & Dinos, G. P. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1018246 · Cited by 5
Self-citation
Cited by
Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., Islam, T., Islam, S., & Haque, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.535668 · Cited by 329
Du, L., Ahmad, S., Liu, L., Wang, L., & Tang, J. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159815 · Cited by 298
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Mahmud, Z., Manik, M. R. K., Rahman, A., Karim, M. M., & Islam, L. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-71472-6 · Cited by 22
Metadata
- Authors
- Dinos, G. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2017-08-10
- Volume
- 174
- Issue
- 18
- Pages
- 2967-2983
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2733572144
- Cited by
- 471
- References
- 164
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.